Form Type: 4

SEC EDGAR Link
Accession Number:0001127602-19-027858
Date:2019-09-01
Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
Original Submission Date:

Reporting Person:

INGRAM ROBERT ALEXANDER
280 S. MANGUM STREET
SUITE 350 DURHAM, NC 27701

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-09-01 A 6,270 a $2.99 28,088 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 shares of common stock issued to the reporting person in lieu of quarterly cash board member retainer of $18,750.
WhaleWisdom Logo

Elevate your investments